Sara Gry Vienberg

Company: Novo Nordisk

Job title: Senior Scientist, Diabetes Biology

Seminars:

Advancing Combination Therapies with Amylin Analogs to Achieve Greater Weight Reduction for Improved Cardiometabolic Health 9:30 am

Combining GLP-1 agonists with amylin analogs for enhanced satiety and glucose control to achieve greater weight reduction for improved cardiometabolic health Optimizing dosing ratios of co-administered peptides for synergistic appetite suppression to maximize weight loss efficacy for reduced caloric intake Evaluating long-term cardiovascular outcomes for comprehensive patient benefit to reduce cardiometabolic risk for enhanced overall…Read more